Two Sigma Securities’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-28,571
| Closed | -$36.9K | – | 1641 |
|
2024
Q4 | $36.9K | Buy |
+28,571
| New | +$36.9K | ﹤0.01% | 1040 |
|
2022
Q4 | – | Sell |
-13,384
| Closed | -$22K | – | 1587 |
|
2022
Q3 | $22K | Buy |
+13,384
| New | +$22K | ﹤0.01% | 1076 |
|
2017
Q2 | – | Sell |
-15,243
| Closed | -$35K | – | 974 |
|
2017
Q1 | $35K | Buy |
+15,243
| New | +$35K | 0.01% | 824 |
|
2016
Q4 | – | Sell |
-15,429
| Closed | -$17K | – | 793 |
|
2016
Q3 | $17K | Buy |
+15,429
| New | +$17K | 0.01% | 611 |
|